Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Nature Communications|November 25, 2024
Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infectionMelissa Kießling, John J Cole, Sabrina Kübel, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategiesEve Todesco, Sophie Sayon, Slim Fourati, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2020
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress SyndromeSophie Hue, Asma Beldi-Ferchiou, Inés Bendib, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 8, 2022
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignanciesSimon B Gressens, Slim Fourati, Anne Le Bouter, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2024
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccineSimon B Gressens, Vincent Enouf, Antoine Créon, et al.
Critical Care (London, England)|December 19, 2020
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 diseaseKeyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, et al.
Critical Care (London, England)|March 23, 2021
Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 diseaseKeyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, et al.
Emerging Infectious Diseases|April 20, 2023
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022Christophe Rodriguez, Laure Boizeau, Alexandre Soulier, et al.
Antiviral Research|December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutationsSlim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Nature Communications|November 25, 2024
Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infectionMelissa Kießling, John J Cole, Sabrina Kübel, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategiesEve Todesco, Sophie Sayon, Slim Fourati, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2020
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress SyndromeSophie Hue, Asma Beldi-Ferchiou, Inés Bendib, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 8, 2022
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignanciesSimon B Gressens, Slim Fourati, Anne Le Bouter, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2024
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccineSimon B Gressens, Vincent Enouf, Antoine Créon, et al.
Critical Care (London, England)|December 19, 2020
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 diseaseKeyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, et al.
Critical Care (London, England)|March 23, 2021
Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 diseaseKeyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, et al.
Emerging Infectious Diseases|April 20, 2023
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022Christophe Rodriguez, Laure Boizeau, Alexandre Soulier, et al.
Antiviral Research|December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutationsSlim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Pageof 19